Dr Agnieszka Michael

Consultant Medical Oncologist

MRCP, PhD

Clinical Interests

  • Gynaecologic oncology
  • Primarily ovarian cancer
  • Urological oncology
  • Kidney cancer
  • Renal cell cancer

Professional Memberships

  • General Medical Council
  • Medical Defence Union
  • Royal College of Physicians

Current NHS and /or University Posts

  • Royal Surrey County Hospital
  • Senior Lecturer, University of Surrey

Research Interests

 - Clinical trials of treatment with new chemotherapy and immunotherapy agents.

 - Management of chemotherapy toxicities in the context of frailty.

 - Supervises several University of Surrey PhD students and oversees research in new biomarkers in ovarian cancer, particularly HOX genes and their targeting, ovarian cancer vaccines and prostate cancer.

Personal profile

Dr Agnieska Michael qualified in medicine at University of Wroclaw in 1994, and undertook general medical and oncology training in London, at St George's Hospital, Royal Marsden Hospital and Guy's and St Thomas' Hospital. 

She was awarded a PhD for research in cancer immunotherapy, with a special interest in cancer vaccines, in 2006 and completed Specialist Training in Medical Oncology in 2007.

Throughout her training and current post Dr Michael has worked in the field of cancer clinical trials, including early phase studies with novel immunotherapy agents, gene therapy and cancer vaccines, as well as international multi-centre phase III and IV studies, as a Chief investigator and a local principal investigator.

Dr Michael is a divisional lead for cancer within Kent, Surrey and Sussex 'Clinical Research Network and since 2015 has been working as a Medical Director for Surrey Clinical Trials Unit.  She is also a Senior Lecturer at the University of Surrey.

Year qualified:

1994